Ask Warren

Korean Drug

014570 · KOSDAQ · ₩014570 · 고려제약

₩2,810▼ ₩30 (1.06%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩18B₩13B₩18B₩16B₩15B₩13B₩18B₩17B
Cost of sales₩9.3B₩7.2B₩11B₩9.6B₩8.1B₩7.8B₩10B₩8.8B
Gross profit₩8.2B₩6.2B₩7.5B₩6.9B₩6.9B₩5.3B₩7.4B₩8.2B
Operating income₩2.7B₩1.2B₩1.9B₩2B₩2.2B₩805M−₩2.5B₩3B
Net income−₩4.6B₩1.2B₩4.6B−₩81M₩1.2B₩802M₩304M₩3.8B
Net income to shareholders−₩4.6B₩1.2B₩4.6B−₩81M₩1.2B₩802M₩304M₩3.8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩99B₩96B₩94B₩95B₩90B₩91B₩89B₩94B
Current assets₩75B₩72B₩69B₩71B₩65B₩66B₩63B₩69B
Cash and equivalents₩11B₩9.4B₩4.9B₩17B₩10B₩5.8B₩4.1B₩5.2B
Total liabilities₩20B₩14B₩11B₩14B₩11B₩14B₩11B₩13B
Current liabilities₩17B₩11B₩8.3B₩9.8B₩8.2B₩10B₩7.2B₩10B
Total equity₩79B₩82B₩83B₩81B₩79B₩77B₩78B₩80B
Shareholders' equity₩79B₩82B₩83B₩81B₩79B₩77B₩78B₩80B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.9B₩6.6B₩988M₩3.7B−₩209M₩8.6B−₩1.2B₩2.5B
Capital spending₩15M₩126M₩49M₩61M₩231M₩116M₩44M₩416M
Free cash flow₩1.9B₩6.5B₩939M₩3.7B−₩439M₩8.5B−₩1.2B₩2.1B
Dividends paid₩0₩1.9B₩0₩0₩0₩1.7B₩0₩0

Consolidated where available. Amounts in won.

Also known as: Korean Drug / 고려제약 / 014570 / KRX:014570

Source: KRX statistical information